| 000 | 01073 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515072652.0 | ||
| 264 | 0 | _c20070918 | |
| 008 | 200709s 0 0 fre d | ||
| 022 | _a0040-5957 | ||
| 024 | 7 |
_a10.2515/therapie:2007025 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCoriat, Romain | |
| 245 | 0 | 0 |
_a[Pro or con the phenotyping/genotyping of patients treated by 5-Fluorouracil to prevent adverse drug reactions?]. _h[electronic resource] |
| 260 |
_bTherapie _c |
||
| 300 |
_a105-9 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadverse effects |
| 650 | 0 | 4 | _aDihydropyrimidine Dehydrogenase Deficiency |
| 650 | 0 | 4 |
_aFluorouracil _xadverse effects |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPhenotype |
| 700 | 1 | _aChaussade, Stanislas | |
| 773 | 0 |
_tTherapie _gvol. 62 _gno. 2 _gp. 105-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2515/therapie:2007025 _zAvailable from publisher's website |
| 999 |
_c17119767 _d17119767 |
||